Summary by Moomoo AI
Vertex Pharmaceuticals Incorporated (Vertex), through its wholly owned subsidiary Adams Merger Sub, Inc. (Purchaser), has announced the commencement of a tender offer to acquire all issued and outstanding shares of Alpine Immune Sciences, Inc. (Alpine). The offer is set at a purchase price of $65.00 per share, net to the seller in cash, without interest and subject to any applicable tax withholding. The tender offer is the initial step in Vertex's strategy to acquire the entire equity interest in Alpine, with plans to subsequently complete a merger, making Alpine a wholly owned subsidiary of Vertex. The offer is subject to certain conditions, including the minimum tender condition, regulatory approvals, and other customary conditions. Vertex expects to file the necessary notifications...Show More